References
Riggio E, Bordoni D, Nava MB (2013) Oncologic surveillance of breast cancer patients after lipofilling. Aesthetic Plast Surg 37:728–735. doi:10.1007/s00266-013-0166-5
Otterburn DM (2013) Discussion for oncologic surveillance of breast cancer patients after lipofilling. Aesthetic Plast Surg 37:736–737. doi:10.1007/s00266-013-0165-6
Beer GM, Varga Z, Budi S, Seifert B, Meyer VE (2002) Incidence of the superficial fascia and its relevance in skin-sparing mastectomy. Cancer 94:1619–1625
Romics L, Chew BK, Weiler-Mithoff E, Doughty JC, Brown IM et al (2012) Ten-year follow-up of skin-sparing mastectomy followed by immediate breast reconstruction. Br J Surg 99:799–806
Harris L, Fritsche H, Mennel R, Norton L, Ravdin P et al (2007) American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 25:5287–5312
Sturgeon CM, Duffy MJ, Stenman UH, Lilja H et al (2008) National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumour markers in testicular, prostate, colorectal, breast, and ovarian cancers. Clin Chem 54:e11–e79
Arvold ND, Taghian AG, Niemierko A, Abi Raad RF et al (2011) Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol 29:3885–3891
van der Hage JA, Mieog JS, van de Velde CJ, Putter H, Bartelink H, van de Vijver MJ (2011) Impact of established prognostic factors and molecular subtype in very young breast cancer patients: pooled analysis of four EORTC randomized controlled trials. Breast Cancer Res 13:R68. doi:10.1186/bcr2908
Cancello G, Maisonneuve P, Rotmensz N, Viale G, Mastropasqua MG et al (2010) Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer. Ann Oncol 21:1974–1981
Mazouni C, Rimareix F, Mathieu MC, Uzan C, Bourgier C, André F, Delaloge S, Garbay JR (2013) Outcome in breast molecular subtypes according to nodal status and surgical procedures. Am J Surg 205:662–667
Voduc KD, Cheang MC, Tyldesley S, Gelmon K, Nielsen TO, Kennecke H (2010) Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 28:1684–1691
Dominici LS, Mittendorf EA, Wang X, Liu J, Kuerer HM, Hunt KK, Brewster A, Babiera GV, Buchholz TA, Meric-Bernstam F, Bedrosian I (2012) Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy. Breast Cancer Res 14:R82
Cianfrocca M, Goldstein LJ (2004) Prognostic and predictive factors in early-stage breast cancer. Oncologist 9:606–616
Hilsenbeck SG, Ravdin PM, de Moor CA, Chamness GC, Osborne CK, Clark GM (1998) Time-dependence of hazard ratios for prognostic factors in primary breast cancer. Breast Cancer Res Treat 52:227–237
Acknowledgments
The authors declare that they have no conflicts of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Riggio, E., Bianchi, G.V. Commentaries on Data Published by Riggio et al. and Discussion by Otterburn on Locoregional Risk Following Mastectomy After Lipofilling. Aesth Plast Surg 38, 608–610 (2014). https://doi.org/10.1007/s00266-014-0280-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00266-014-0280-z